A Pilot Trial of Continuous Glucose Monitoring Upon Emergency Department Discharge Among People With Diabetes Mellitus

Endocr Pract. 2024 Feb;30(2):122-127. doi: 10.1016/j.eprac.2023.11.001. Epub 2023 Nov 10.

Abstract

Objective: People with diabetes mellitus, particularly those with limited access to longitudinal care, frequently present to the emergency department (ED). Continuous glucose monitoring (CGM) has been shown to improve outcomes in ambulatory settings, so we hypothesized that it would be beneficial if initiated upon ED discharge.

Methods: We randomized adults with diabetes who were seen in the ED for hypo- or hyperglycemia to either 14 days of flash CGM or care coordination alone. All participants were scheduled to follow up in our diabetes specialty clinic. Outcomes included clinic attendance, the 3-month change in hemoglobin A1c, and repeat ED utilization.

Results: We recruited 30 participants, including 13 with newly diagnosed diabetes. All but one (97%) had type 2 diabetes. We found no significant difference between the CGM (n = 16) and control (n = 14) groups in terms of clinic attendance (75 vs 64%, P = .61) or repeat ED utilization (31 vs 50%, P = .35), although our power was low. The absolute reduction in A1c was greater in the CGM group (5.2 vs 2.4%, P = .08). Among newly diagnosed participants for whom we had data, 7 out of 7 in the CGM group had a follow-up A1c under 7% compared to 1 out of 3 in the control group (P = .03). Over 90% of patients and providers found the CGM useful.

Conclusions: Our data demonstrate the feasibility of starting CGM in the ED, a valuable setting for engaging difficult-to-reach patients. Our pilot study was limited by its small sample size, however, as recruitment in the ED can be challenging.

Keywords: CGM; continuous glucose monitoring; emergency department; type 2 diabetes.

MeSH terms

  • Adult
  • Blood Glucose
  • Blood Glucose Self-Monitoring
  • Continuous Glucose Monitoring
  • Diabetes Mellitus, Type 1*
  • Diabetes Mellitus, Type 2* / therapy
  • Glycated Hemoglobin
  • Humans
  • Hypoglycemia* / diagnosis
  • Hypoglycemic Agents
  • Patient Discharge
  • Pilot Projects

Substances

  • Blood Glucose
  • Glycated Hemoglobin
  • Hypoglycemic Agents